Rivaroxaban
Indication:
Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF)
Product Features
Form:
Film Coated Tablets
Active Ingredient:
Rivaroxaban
Active Ingredient Amount:
20 mg
Commercial Figure:
In blister packages of 28 film-coated tablets